Ashira Dermatology is currently seeking individuals who suffer from severe Atopic Dermatitis for active clinical trial.
The purpose of this trial is to evaluate the efficacy and safety of the investigational study medication in adolescents
(12-17 years old) and adults (18-75 years old) with moderate to severe Atopic Dermatitis, also known as Eczema.
The study medication is a tablet and will be taken by mouth.
Who may participate in this study?
Your child may be eligible to participate if:
Your child is aged 12 or more years old
Your child has moderate to severe Atopic Dermatitis
Your child is experiencing active Atopic Dermatitis symptoms, such as: itchiness, irritated dry skin,
There are other eligibility requirements.
A final decision on whether this research study might be suitable for your
child will be made after you and your child speak with the study doctor at the research site. The study doctor will
explain the benefits and risks of participation in this research study.
You may receive reimbursement for your time and travel expenses related to study participation.